Novacea ends late-stage trial of prostate cancer drug (Reuters)

[DocJohn]

(From Yahoo) Reuters - Drugmaker Novacea Inc ended a late-stage trial of its prostate cancer drug Asentar, after a treatment arm containing the drug showed a higher death rate compared with the standard care, driving shares down more than 69 percent to a lifetime low.

Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/nm/20071105/hl_nm/novacea_asentar_dc)